Company intelligence / Profile preview

Numantec

Ownership: Private
Employees: ~400
Development stage: Commercial

Overview

Numantec designs, manufactures, and distributes certified medical devices with a focus on infusion therapy systems such as vascular access catheters, elastomeric pumps, pre-filled syringes, traditional syringes as well as urology and critical care products. The group has grown through strategic acquisitions to become a European leader in its field. It recently expanded into the US market by acquiring Health Line International Corp., further strengthening its global presence in critical care vascular access.

Therapeutic areas: OtherCardiovascularGastroenterologyMen's Health
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

No major external pharmaceutical partnerships disclosed; recent acquisition of Health Line expands US reach with continued collaboration with Faulkner family management team at Health Line.

Beyond the preview

Go deeper on Numantec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Numantec.

Explore the full profile